Design of biosimilars to overcome the limitations of neuromodulation of the inflammation
Publication
, Journal Article
Ulloa, L
Published in: Journal of Biotechnology & Biomaterials
2016
Published In
Journal of Biotechnology & Biomaterials
DOI
EISSN
2155-952X
Publication Date
2016
Volume
06
Issue
05
Publisher
OMICS Publishing Group
Citation
APA
Chicago
ICMJE
MLA
NLM
Ulloa, L. (2016). Design of biosimilars to overcome the limitations of neuromodulation of the inflammation. Journal of Biotechnology & Biomaterials, 06(05). https://doi.org/10.4172/2155-952x.c1.057
Ulloa, Luis. “Design of biosimilars to overcome the limitations of neuromodulation of the inflammation.” Journal of Biotechnology & Biomaterials 06, no. 05 (2016). https://doi.org/10.4172/2155-952x.c1.057.
Ulloa L. Design of biosimilars to overcome the limitations of neuromodulation of the inflammation. Journal of Biotechnology & Biomaterials. 2016;06(05).
Ulloa, Luis. “Design of biosimilars to overcome the limitations of neuromodulation of the inflammation.” Journal of Biotechnology & Biomaterials, vol. 06, no. 05, OMICS Publishing Group, 2016. Crossref, doi:10.4172/2155-952x.c1.057.
Ulloa L. Design of biosimilars to overcome the limitations of neuromodulation of the inflammation. Journal of Biotechnology & Biomaterials. OMICS Publishing Group; 2016;06(05).
Published In
Journal of Biotechnology & Biomaterials
DOI
EISSN
2155-952X
Publication Date
2016
Volume
06
Issue
05
Publisher
OMICS Publishing Group